![](/media/vdqhqzem/salmon.png)
Uppsala Reports editor
@UMCGlobalSafety
WHO programme / 15 April 2020
Photo: iStock
The WHO Programme for International Drug Monitoring continues to grow. Since we last reported on programme membership (Issue 81, October 2019), three countries have become full members: Luxembourg (January 2020), Saint Vincent and the Grenadines (March), and Nicaragua (April). In addition, Belize and Dominican Republic joined as associate members (January and March, respectively).
The programme now stands at 139 full and 32 associate members.
Read more:
The film explores the changing landscape of vaccine surveillance and UMC’s role in supporting the WHO PIDM through the tumultuous pandemic.
WHO programme / 10 October 2023
Since its introduction 20 years ago, UMC’s adverse event reporting system has become the world’s most widely used safety surveillance toolkit for medicines and vaccines.
WHO programme / 25 November 2024
The theme of this year’s WHO PIDM programme members meeting investigated the true value of social media in signal detection and creating effective communication strategies.
WHO programme / 19 October 2023